newsfilter
← Latest News
GlobeNewswire·

Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics,